Bigger Data = Better Data: Detect 7,000 proteins at once with high throughput to optimize biomarker discovery


The ideal biomarkers are waiting to be revealed within the human proteome. Big data from many thousands of protein analytes leads to superior biomarker models across therapeutic areas. In this webinar you will discover how machine learning can be harnessed to select the right targets and build the right models for your research. You will also learn how to develop models, identify and mediate clinical risk, and elevate your research with greater precision than ever.

Image of Joe Gogain, SomaLogic Director of Clinical R&D

Joe Gogain, PhD

Clinical R&D at SomaLogic

Joe Gogain is a Director of Clinical Research and Development at SomaLogic, Inc., where he works closely with collaborating partners developing diagnostic and prognostic proteomic applications. Joe is a biological scientist with molecular diagnostic and immunoassay development expertise. Joe has a proven track record of IVD product development under design control and experience in de novo 510(k) regulatory submission processes and requirements. Additionally, Joe has served as a director of national clinical trials for point-of-care diagnostic devices and has experience managing a variety of technicians, scientists and clinical operations personnel.

Bigger Data = Better Data: Detect 7,000 proteins at once with high throughput to optimize biomarker discovery

A webinar presented by Joe Gogain, PhD

Share with colleagues

More webinars

WebinarUsing non-hypothesized based approaches for biomarker development

Current biomarkers are only moderately predictive in identifying individuals with mild traumatic brain injury or concussion. Therefore, more accurate diagnostic markers are needed for sport-related concussion (SRC).

Learn more

WebinarAssessment of variability and normalization methods using the plasma 7K SomaScan® Assay v4.1

In this webinar, the speakers present the largest technical assessment of this platform to date based on a study of 2,050 samples across 22 plates.

Learn more

WebinarThe proteomics of aging: how technology is advancing research

Please join us to hear four experts discuss the present challenges and opportunities for proteomics in aging research: Eric Morgen, COO of BioAge Labs; Paola Sebastiani, faculty biostatistician at Tufts Medical Center and PI on the Longevity Consortium; Birgit Schilling, associate professor, Buck Institute for Research on Aging; and Alessandro Ori, group leader at the Leibniz Institute on Aging.

Learn more